NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
China Sky One Medical,Inc. »19/03/2010 [Industry news]
China recognizes Antroquinonol as Breakthrough Drug

China Sky One Medical announced that Antroquinonol (Hocena) capsule, a new anti-cancer drug co-developed with Taiwan Golden Biotechnology was recognized as Breakthrough Drug by the Chinese Ministry of Science and Technology.

 
China Sky One Medical announced that Antroquinonol (Hocena) capsule, a new anti-cancer drug co-developed with Taiwan Golden Biotechnology was recognized as \'Breakthrough Drug\' by the Chinese Ministry of Science and Technology. In order to promote innovation within the Chinese pharmaceutical industry, the Chinese Ministry of Science and Technology (MoST) and Chinese Ministry of Health (MoH) launched a project to support the research and development of breakthrough drugs which are used to treat cancer, AIDS, and cardio- and cerebro-vascular diseases. The government will not only accelerate the processing of new drug applications but also provide financial and technical support for these breakthrough drugs. “We are honored to receive this recognition and we appreciate the government\'s support for our R&D efforts, which reinforces our commitment to expand our drug portfolio and develop high-value drugs. The Antroquinonol capsule is the first drug to be recognized as Breakthrough Drug in the Heilongjiang Province. We anticipate its research progress and new drug application procedures will be greatly shortened. We look forward to receiving the approval to enter into clinical trial within one year and we hope to receive SFDA final approval for production within three years,\" said Mr Yan-Qing Liu, Chairman and CEO of China Sky One Medical. In May 2009, the company signed an agreement with Taiwan Golden Biotechnology to begin cooperating on the development of Antroquinonol, which is a kind of compound extracted from Antrodia Cinnamomea Chang & Chou, a rare medicinal fungus that grows naturally inside the Cinnamonum kanehirae tree trunk, a native tree species of Taiwan. It can be used in the treatment of liver cancer and lung cancer. Antroquinonol has been approved by the US FDA to enter into first stage clinical trial.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.